Beginning Cash: The amount of cash reported by the company on its previous statement.
Zentalis Pharmaceuticals, Inc. (ZNTL) had Beginning Cash of $38.62M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-42.29M |
|
-- |
|
-- |
|
$44.39M |
|
$-44.39M |
|
$2.24M |
|
$-42.15M |
|
$-42.15M |
|
$-42.29M |
|
$-42.29M |
|
$-42.29M |
|
$-42.29M |
|
$-44.39M |
|
$-44.29M |
|
71.33M |
|
71.33M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$181.28M |
|
$2.50M |
|
$34.05M |
|
$215.33M |
|
$37.63M |
|
-- |
|
$34.06M |
|
$71.68M |
|
$143.65M |
|
$143.65M |
|
$143.65M |
|
71.67M |
|
| Cash Flow Statement Financials | |
$-70.19M |
|
$60.04M |
|
$-1.06M |
|
|
Beginning Cash |
$38.62M |
$27.41M |
|
$-11.21M |
|
$6.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.44% |
|
-29.44% |
|
-19.64% |
|
-29.44% |
|
$2.00 |
|
$-0.98 |
|
$-0.98 |
|